179 related articles for article (PubMed ID: 12570851)
1. The design of G-quadruplex ligands as telomerase inhibitors.
Cuesta J; Read MA; Neidle S
Mini Rev Med Chem; 2003 Feb; 3(1):11-21. PubMed ID: 12570851
[TBL] [Abstract][Full Text] [Related]
2. G-Quadruplex ligands: Potent inhibitors of telomerase activity and cell proliferation in Plasmodium falciparum.
Calvo EP; Wasserman M
Mol Biochem Parasitol; 2016 May; 207(1):33-8. PubMed ID: 27217226
[TBL] [Abstract][Full Text] [Related]
3. G-quadruplexes as therapeutic targets.
Neidle S; Read MA
Biopolymers; 2000-2001; 56(3):195-208. PubMed ID: 11745111
[TBL] [Abstract][Full Text] [Related]
4. Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition.
Bhattacharya S; Chaudhuri P; Jain AK; Paul A
Bioconjug Chem; 2010 Jul; 21(7):1148-59. PubMed ID: 20536245
[TBL] [Abstract][Full Text] [Related]
5. Design of telomerase inhibitors for the treatment of cancer.
Cairns D; Anderson RJ; Perry PJ; Jenkins TC
Curr Pharm Des; 2002; 8(27):2491-504. PubMed ID: 12369943
[TBL] [Abstract][Full Text] [Related]
6. [Telomeres and telomerase, new targets for anticancer chemotherapy].
Riou JF; Morjani H; Trentesaux C
Ann Pharm Fr; 2006 Mar; 64(2):97-105. PubMed ID: 16568010
[TBL] [Abstract][Full Text] [Related]
7. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex.
Kim MY; Vankayalapati H; Shin-Ya K; Wierzba K; Hurley LH
J Am Chem Soc; 2002 Mar; 124(10):2098-9. PubMed ID: 11878947
[TBL] [Abstract][Full Text] [Related]
8. Telomerase: biology and phase I trials.
Kelland LR
Lancet Oncol; 2001 Feb; 2(2):95-102. PubMed ID: 11905801
[TBL] [Abstract][Full Text] [Related]
9. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships among guanine-quadruplex telomerase inhibitors.
Neidle S; Harrison RJ; Reszka AP; Read MA
Pharmacol Ther; 2000 Mar; 85(3):133-9. PubMed ID: 10739868
[TBL] [Abstract][Full Text] [Related]
11. Nucleic acids as targets for antitelomerase agents.
Alberti P; Lacroix L; Guittat L; Hélène C; Mergny JL
Mini Rev Med Chem; 2003 Feb; 3(1):23-36. PubMed ID: 12570852
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-based melting assays for studying quadruplex ligands.
De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
[TBL] [Abstract][Full Text] [Related]
13. Arylsulfanyl groups - Suitable side chains for 5-substituted 1,10-phenanthroline and nickel complexes as G4 ligands and telomerase inhibitors.
Liu W; Wang S; Dotsenko IA; Samoshin VV; Xue L
J Inorg Biochem; 2017 Aug; 173():12-20. PubMed ID: 28476011
[TBL] [Abstract][Full Text] [Related]
14. BRACO19 analog dimers with improved inhibition of telomerase and hPot 1.
Fu YT; Keppler BR; Soares J; Jarstfer MB
Bioorg Med Chem; 2009 Mar; 17(5):2030-7. PubMed ID: 19201200
[TBL] [Abstract][Full Text] [Related]
15. G-quadruplex interacting agents targeting the telomeric G-overhang are more than simple telomerase inhibitors.
Riou JF
Curr Med Chem Anticancer Agents; 2004 Sep; 4(5):439-43. PubMed ID: 15379700
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
17. G-Quadruplex DNA as a target for drug design.
Kerwin SM
Curr Pharm Des; 2000 Mar; 6(4):441-78. PubMed ID: 10788591
[TBL] [Abstract][Full Text] [Related]
18. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay.
Mergny JL; Lacroix L; Teulade-Fichou MP; Hounsou C; Guittat L; Hoarau M; Arimondo PB; Vigneron JP; Lehn JM; Riou JF; Garestier T; Hélène C
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3062-7. PubMed ID: 11248032
[TBL] [Abstract][Full Text] [Related]
19. Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders.
Alcaro S; Artese A; Costa G; Distinto S; Ortuso F; Parrotta L
Biochimie; 2011 Aug; 93(8):1267-74. PubMed ID: 21699954
[TBL] [Abstract][Full Text] [Related]
20. Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA.
Maji B; Bhattacharya S
Chem Commun (Camb); 2014 Jun; 50(49):6422-38. PubMed ID: 24695755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
